Origins of Cystic Fibrosis Lung Disease

被引：100
|
作者：
Munder, Antje [1 ]
Tuemmler, Burkhard [1 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 372卷 / 16期
关键词：
D O I：
10.1056/NEJMc1502191
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1574 / 1574
页数：1
相关论文
共 50 条
  • [21] Genetic therapies for cystic fibrosis lung disease
    Sinn, Patrick L.
    Anthony, Reshma M.
    McCray, Paul B., Jr.
    HUMAN MOLECULAR GENETICS, 2011, 20 : R79 - R86
  • [22] Update on pathogenesis of cystic fibrosis lung disease
    Donaldson, SH
    Boucher, RC
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (06) : 486 - 491
  • [23] Emerging therapies for cystic fibrosis lung disease
    Rubin, BK
    CHEST, 1999, 115 (04) : 1120 - 1126
  • [24] Emerging therapies for cystic fibrosis lung disease
    Grasemann, Hartmut
    Ratjen, Felix
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (04) : 653 - 659
  • [25] Antioxidant supplementation for lung disease in cystic fibrosis
    Ciofu, Oana
    Lykkesfeldt, Jens
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [26] Role of corticosteroids in cystic fibrosis lung disease
    BalfourLynn, IM
    Dinwiddie, R
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 : 8 - 13
  • [27] PERFUSION MRI IN CYSTIC FIBROSIS LUNG DISEASE
    Wielpuetz, Mark O.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S204 - S204
  • [28] Cystic Fibrosis Lung Disease in the Aging Population
    Kunzi, Lisa
    Easter, Molly
    Hirsch, Meghan June
    Krick, Stefanie
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [29] Cystic fibrosis lung disease in adult patients
    Vender, Robert L.
    POSTGRADUATE MEDICINE, 2008, 120 (01) : 64 - 74
  • [30] Innate immunity in cystic fibrosis lung disease
    Hartl, D.
    Gaggar, A.
    Bruscia, E.
    Hector, A.
    Marcos, V.
    Jung, A.
    Greene, C.
    McElvaney, G.
    Mall, M.
    Doering, G.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (05) : 363 - 382
12345